Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis.

Autor: Connors KA; Department of Infectious Diseases and Microbiology, School of Public Health, and.; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Chapman NS; Department of Pathology, Microbiology and Immunology, and.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA., McMillen CM; Department of Infectious Diseases and Microbiology, School of Public Health, and.; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hoehl RM; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., McGaughey JJ; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Frey ZD; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Midgett M; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Williams C; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Reed DS; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Crowe JE Jr; Department of Pathology, Microbiology and Immunology, and.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hartman AL; Department of Infectious Diseases and Microbiology, School of Public Health, and.; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Publikováno v: JCI insight [JCI Insight] 2024 Aug 01; Vol. 9 (18). Date of Electronic Publication: 2024 Aug 01.

A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model.

Autor: McMillen CM; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, PA, USA.; University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, PA, USA., Chapman NS; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, TN, USA., Hoehl RM; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, PA, USA., Skvarca LB; University of Pittsburgh Medical Center, Magee-Womens Hospital, Department of Pathology, Pittsburgh, PA, USA., Schwarz MM; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, PA, USA.; University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, PA, USA., Handal LS; Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, TN, USA., Crowe JE Jr; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, TN, USA. james.crowe@vumc.org.; Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, TN, USA. james.crowe@vumc.org.; Vanderbilt University Medical Center, Department of Pediatrics, Nashville, TN, USA. james.crowe@vumc.org., Hartman AL; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, PA, USA. hartman2@pitt.edu.; University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, PA, USA. hartman2@pitt.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Jul 26; Vol. 14 (1), pp. 4507. Date of Electronic Publication: 2023 Jul 26.

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.

Autor: Engdahl TB; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States., Binshtein E; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States., Brocato RL; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States., Kuzmina NA; Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, United States.; Galveston National Laboratory, Galveston, United States., Principe LM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States., Kwilas SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States., Kim RK; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States., Chapman NS; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States., Porter MS; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States., Guardado-Calvo P; Institut Pasteur, Université Paris Cité, Paris, France., Rey FA; Institut Pasteur, Université Paris Cité, Paris, France., Handal LS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States., Diaz SM; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States., Zagol-Ikapitte IA; Department of Biochemistry and Mass Spectrometry Research Center, Vanderbilt University, Nashville, United States., Tran MH; Department of Biochemistry and Mass Spectrometry Research Center, Vanderbilt University, Nashville, United States., McDonald WH; Department of Biochemistry and Mass Spectrometry Research Center, Vanderbilt University, Nashville, United States., Meiler J; Department of Chemistry, Vanderbilt University, Nashville, United States., Reidy JX; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States., Trivette A; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States., Bukreyev A; Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, United States.; Galveston National Laboratory, Galveston, United States.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, United States., Hooper JW; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States., Crowe JE; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, United States.

Publikováno v: ELife [Elife] 2023 Mar 27; Vol. 12. Date of Electronic Publication: 2023 Mar 27.

Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.

Autor: Chapman NS; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232.; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., Zhao H; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110., Kose N; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., Westover JB; Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322., Kalveram B; Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555., Bombardi R; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., Rodriguez J; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., Sutton R; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., Genualdi J; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232., LaBeaud AD; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305., Mutuku FM; Department of Environment and Health Sciences, Technical University of Mombasa, Mombasa, Kenya., Pittman PR; Medical Research and Material Command, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702., Freiberg AN; Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch at Galveston, Galveston, TX 77555.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch at Galveston, Galveston, TX 77555., Gowen BB; Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322., Fremont DH; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110., Crowe JE Jr; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232; james.crowe@vumc.org.; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Apr 06; Vol. 118 (14).

An Introduction to Rift Valley Fever Virus.

Autor: Weber F; Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Giessen, Germany., Bouloy M; Institut Pasteur, Université Paris Cité, Bunyavirus Molecular Genetics Unit, Paris, France., Lozach PY; IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France. pierre-yves.lozach@inrae.fr.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2824, pp. 1-14.